Bryan Bean, MD
Orthopaedic Surgery · Nashua, NHNPI 1164832770
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.3%), education and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Cerapedics Inc. at 35.0% of the total. Reporting peaked in 2021 at $4,722 and has fallen 67.6% since, to $1,528 in 2025.
Across 101 payments — averaging $105.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerapedics Inc.$4K
- Kairos Surgical Inc$3K
- Stryker$2K
- Paragon 28, Inc.$544
- Pacira Pharmaceuticals Incorporated$241
- Johnson & Johnson$238
- plus $759 from 13 others
What the payments were for
- Consulting fees$3,12529%
- Travel & lodging$8208%
- Food & beverage$3,54833%
- Education$3,15130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerapedics Inc. | 8 | $3,723 |
| Kairos Surgical Inc | 7 | $3,257 |
| Stryker(2 entities) | 20 | $1,882 |
| Paragon 28, Inc. | 20 | $544 |
| Pacira Pharmaceuticals Incorporated | 13 | $241 |
| Johnson & Johnson | 2 | $238 |
| Bioventus LLC | 5 | $129 |
| Endo Pharmaceuticals Inc. | 4 | $90 |
| Zimmer Biomet | 2 | $83 |
| Vertex | 4 | $74 |
| Endo USA, Inc. | 3 | $74 |
| Ferring Pharmaceuticals Inc. | 3 | $58 |
| Amgen | 2 | $53 |
| Exactech, Inc. | 1 | $50 |
| Smith+Nephew | 2 | $40 |
| Orthofix Medical, Inc. | 2 | $39 |
| Medshape, Inc. | 1 | $26 |
| Boston Scientific | 1 | $22 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$7,359
- INFINITY$763
- INCOMPASS TOTAL ANKLE SYSTEM$255
- DART-FIRE$161
- DYNACORD$128
- HEALIX$128
- MINILOK$128
- ASNIS$127
- HAMMERLOCK$110
- HEADLESS COMPRESSION SCREWS$110
How this compares
$10,644 in reported general payments places this provider in the 75th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 26 | $131 |
| Meloxicam | 39 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $79 |
| Methylprednisolone | 13 | $44 |
| Amoxicillin | 14 | $8 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashua
- David RichardsNashua$122K
- Christian KlareNashua$88K
- Matthew WilkeningNashua$79K
- Thomas FortneyNashua$54K
- Peter EyvazzadehNashua$19K
- Anand PadmanabhaNashua$16K
- Andrew GarberNashua$9K
- Jason SmoakNashua$8K
- James BargerNashua$7K
- Daniel BouvierNashua$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.